AI assistant
AtriCure, Inc. — Director's Dealing 2020
Feb 24, 2020
31802_dirs_2020-02-24_68511a5a-b963-4a0e-af07-5ed6eab7c27f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2020-02-21
Reporting Person: Wade M. Andrew (CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-02-21 | Common Stock | M | 15000 | $6.27 | Acquired | 160120 | Direct |
| 2020-02-21 | Common Stock | S | 15000 | $39.45 | Disposed | 145120 | Direct |
| 2020-02-21 | Common Stock | M | 15000 | $6.73 | Acquired | 160120 | Direct |
| 2020-02-21 | Common Stock | S | 15000 | $39.46 | Disposed | 145120 | Direct |
| 2020-02-21 | Common Stock | M | 15000 | $6.73 | Acquired | 160120 | Direct |
| 2020-02-21 | Common Stock | S | 15000 | $39.45 | Disposed | 145120 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-02-21 | Stock Option (Right to Buy) | $6.27 | M | 15000 | Disposed | 2022-10-25 | Common Stock (15000) | Direct |
| 2020-02-21 | Stock Option (Right to Buy) | $6.73 | M | 15000 | Disposed | 2022-12-27 | Common Stock (15000) | Direct |
| 2020-02-21 | Stock Option (Right to Buy) | $6.73 | M | 15000 | Disposed | 2022-12-27 | Common Stock (15000) | Direct |
Footnotes
F1: These shares were exercised pursuant to a 10b5-1 trading plan.
F2: These shares were sold pursuant to a 10b5-1 trading plan.
F3: This transaction was executed in multiple trades at prices ranging from $38.94 to $40.60 per share. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4: These options were granted on October 25, 2012. The options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years.
F5: These options were granted on December 27, 2012 and are exercisable as to 25% of the shares one year from the date of grant, and the remaining 75% thereafter vests and is exercisable in equal monthly installments on the same day of the month over the following three years.